SUBJECT
title
A Resolution of the City Council of the City of Laredo, Texas, authorizing the City Manager to accept and enter into a continuation contract from the Health Resources & Services Administration, HIV Ryan White 340B drug pricing reimbursement program, for the total amount of $370,000.00, with no match for the City of Laredo Public Health Department for the term period from April 01, 2025 through March 31, 2026. Funds will be accounted for in the Laredo Public Health Department Fund - HIV Ryan White 340B Program.
body
VIVA LAREDO PLAN ALIGNMENT
Alignment Rating: Strong
Supporting goal(s)/policy(ies):
• Goal 7.1: Address the health needs of all residents in the region through collaboration and coordination among local, state, and binational entities.
• Policy 7.1.1: Partner with local, state, and binational entities to prevent health-related problems through prevention programs and policies.
• Policy 7.2.5: Reduce infectious and communicable diseases and infection.
Summary of alignment: The Ryan White 340B Program funding aligns strongly with the Viva Laredo Comprehensive Plan, particularly in advancing equitable access to essential medical treatments for underserved populations living with HIV. The program utilizes federal pricing discounts to provide cost-effective medications and comprehensive HIV-related services-directly supporting Laredo’s efforts to expand access and reduce barriers to care.
PREVIOUS COUNCIL ACTION
On March 03, 2025, Council approved Ordinance 2025-O-30.
BACKGROUND
The Health Resources & Services Administration (HRSA) 340B Program enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services. Eligible health care organizations/covered entities are defined in statute and include HRSA-supported health centers and look-alikes, Ryan White clinics and State AIDS Drug Assistance programs. To participate in the 340B Program, eligible organizations and covered entities must register and be enrolled with the 340B program and comply with all 340B Program requirements. Once enrolled, covered entities are assigned a 340B identification number that vendors verify before allowing an organization to purchase 340B discounted drugs, expanding pharmaceutical access to underserved, uninsured, and low-income populations.
COMMITTEE RECOMMENDATION
N/A
STAFF RECOMMENDATION
recommendation
Staff recommends that Council approve the Resolution.
end
Fiscal Impact
Fiscal Year: 2025
Budgeted Y/N?: Y
Source of Funds: Ryan White 340B Program
Account #: 226-6020
Change Order: Exceeds 25% Y/N: N/A
FINANCIAL IMPACT:
The revenue account 226-0000-376-0702 and the expenditure division is 226-6020 with Project Number HERP02.